Role of growth hormone in chronic heart failure: Therapeutic implications

Drugs

Volumn 60, Issue 4, 2000, Pages 711-719

  Volterrani, M ^a   Manelli, F ^b   Cicoira, M ^c   Lorusso, R ^d   Giustina, A ^b  

^a IRCCS   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

^c UNIVERSITY OF VERONA   (Italy)

^d SPEDALI CIVILI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; HUMAN GROWTH HORMONE;

ACROMEGALY; CARDIOMYOPATHY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MECHANISM; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HEART FAILURE; HEART FUNCTION; HORMONAL THERAPY; HORMONE METABOLISM; HORMONE STRUCTURE; HUMAN; MULTICENTER STUDY; PATHOGENESIS; RANDOMIZED CONTROLLED TRIAL; REVIEW;

ANIMALIA;

EID: 0033756825     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-200060040-00002     Document Type: Review

References (57)

1. Ultrastructural-immunocytochemical localization of growth hormone and prolactin in human pituitaries
2. Variants of growth hormone and prolactin and their post-translational modifications
3. Basal plasma growth hormone levels in man: New evidence for rhythmicity of growth hormone secretion
4. Mode of action of pituitary growth hormone on target cells
5. Serum insulin-like growth factor-binding-3 levels in the diagnosis of acromegaly
6. Basic counterpoint: Mechanisms and pathways of gonadal steroid modulation of growth hormone secretion
7. Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human
8. Action of insulin-like growth factors
9. Regulation of rat growth hormone receptor gene expression
10. Insulin like growth factor-I induces hypertrophy with enhanced expression of muscle specific genes in cultured rat cardiomyocytes
11. Left ventricular insulin like growth factor I increases in early renal hypertension
12. Characterization of the paradoxical growth hormone inhibitory effect of galanin in acromegaly
13. Treatment with growth hormone enhances contractile reserve and intracellular calcium transients in myocytes from rats with postinfarction heart failure
14. Mortality in acromegaly
15. Cell death in acromegalic cardiomyopathy
16. Evidence for biventricular involvement in acromegaly: A Doppler echocardiographic study
17. Echocardiographic assessment of cardiac anatomy and function in acromegalic patients
18. Growth hormone and the heart
19. Acromegalic cardiopathy improves after treatment with increasing doses of octreotide
20. Rapid reduction of left ventricular hypertrophy in acromegaly after suppression of growth hormone hypersecretion
21. Cardiopulmonary performance during exercise in acromegaly, and the effects of acute suppression of growth hormone hypersecretion with octreotide
22. Three years follow-up of acromegalic patients treated with intramuscular slow-release lanreotide
23. Cardiovascular effects of a single slow release lanreotide injection in patients with acromegaly and left ventricular hypertrophy
24. The growth hormone deficiency in adults
25. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency
26. Impaired cardiac performance in growth hormone deficiency adults and its improvement after growth hormone replacement
27. Effect of long-term rhGH administration in GH-deficient adults on fat cell epinephrine response
28. Cardiovascular and renal effects of growth hormone
29. Effect of growth hormone therapy on early atherosclerotic changes in GH-deficient adults
30. The role of glucocorticoids in the regulation of growth hormone secretion
31. The neuroendocrine regulation and implications of pulsatile GH secretion: Gender effects
32. Radioimmunological determination of insulin like growth factors I and II in normal subjects and in patients with growth disorders and extrapancreatic tumor hypoglycemia
33. Growth hormone neuroregulation in diabetes mellitus
34. Clinical features and endocrine status in patients with growth hormone insensitivity (Laron syndrome)
35. Endocrine predictors of the acute hemodynamic effects of growth hormone in congestive heart failure
36. Alterations in the pulsatile mode of growth hormone release in men and women with insulin-dependent diabetes mellitus
37. Differential effects of feeding on the ultradian variation of the growth hormone (GH) response to GH-releasing hormone in normal subjects and patients with obesity and anorexia nervosa
38. Insulin-like growth factors and insulin increase the contractility of neonatal rat cardiocytes in vitro
39. Hemodynamic effects of intravenous growth hormone in congestive heart failure
40. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality
41. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure
42. Plasma norepinephrine, plasma renin activity, and congestive heart failure: Relations to survival and the effects of the therapy in V-HeFT II
43. Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure
44. Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)
45. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy
46. The Cardiac Insufficiency Bisoprolol Study II (CIBIS II): A randomized trial
47. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Interventional Trial in Congestive Heart Failure (MERIT-HF)
48. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia
49. Cardiac failure responding to growth hormone
50. A preliminary study of growth hormone in the treatment of dilated cardiomyopathy
51. Growth hormone in the treatment of dilated cardiomyopathy
52. Treatment of endstage cardiac failure with growth hormone
53. Randomised, double blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy
54. A placebo-controlled study of growth hormone in patients with congestive heart failure
55. Recombinant growth hormone therapy in patients with ischemic cardiomyopathy: Effects on hemodynamics, left ventricular function and cardiopulmonary exercise capacity
56. Growth hormone resistance in chronic heart failure
57. Pulsatile intravenous growth hormone (GH) infusion to hypophysectomised rats increases insulin-like growth factor I messenger ribonucleic acid more effectively than continuous growth hormone infusion